&lt;?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://mounjaronews.info/</loc><changefreq>daily</changefreq><priority>1.0</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/"/></url><url><loc>https://mounjaronews.info/posts/2026-05-12-benefits-of-starting-mounjaro-and-ozempic-early-making-sense/</loc><lastmod>2026-05-12T09:34:58+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-12-benefits-of-starting-mounjaro-and-ozempic-early-making-sense/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-12-benefits-of-starting-mounjaro-and-ozempic-early-making-sense/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-12T09:34:58+01:00</news:publication_date><news:title>Benefits of Starting Mounjaro and Ozempic Early - Making Sense of Diabetes</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-12-how-to-get-tirzepatide-eligibility-criteria-cost-and-more/</loc><lastmod>2026-05-12T09:34:50+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-12-how-to-get-tirzepatide-eligibility-criteria-cost-and-more/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-12-how-to-get-tirzepatide-eligibility-criteria-cost-and-more/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-12T09:34:50+01:00</news:publication_date><news:title>How To Get Tirzepatide: Eligibility Criteria, Cost And More</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-12-tirzepatide-mounjaro-type-2-diabetes-drug-guide-everyday-hea/</loc><lastmod>2026-05-12T09:34:42+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-12-tirzepatide-mounjaro-type-2-diabetes-drug-guide-everyday-hea/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-12-tirzepatide-mounjaro-type-2-diabetes-drug-guide-everyday-hea/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-12T09:34:42+01:00</news:publication_date><news:title>Tirzepatide (Mounjaro): Type 2 Diabetes Drug Guide - Everyday Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-11-does-mounjaro-help-with-erectile-dysfunction-portal-cnj/</loc><lastmod>2026-05-11T10:36:04+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-11-does-mounjaro-help-with-erectile-dysfunction-portal-cnj/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-11-does-mounjaro-help-with-erectile-dysfunction-portal-cnj/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-11T10:36:04+01:00</news:publication_date><news:title>Does Mounjaro Help with Erectile Dysfunction - Portal CNJ</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-11-mounjaro-remains-number-one-in-india-as-torrent-captures-38-/</loc><lastmod>2026-05-11T10:35:56+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-11-mounjaro-remains-number-one-in-india-as-torrent-captures-38-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-11-mounjaro-remains-number-one-in-india-as-torrent-captures-38-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-11T10:35:56+01:00</news:publication_date><news:title>Mounjaro remains number one in India as Torrent captures 38% of the generic semaglutide market - The South First</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-11-eli-lilly-s-mounjaro-surpasses-merck-s-keytruda-as-best-sell/</loc><lastmod>2026-05-11T10:35:50+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-11-eli-lilly-s-mounjaro-surpasses-merck-s-keytruda-as-best-sell/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-11-eli-lilly-s-mounjaro-surpasses-merck-s-keytruda-as-best-sell/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-11T10:35:50+01:00</news:publication_date><news:title>Eli Lilly's Mounjaro Surpasses Merck's Keytruda as Best-Selling Drug</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-10-can-mounjaro-help-with-erectile-dysfunction-portal-cnj/</loc><lastmod>2026-05-10T08:51:07+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-10-can-mounjaro-help-with-erectile-dysfunction-portal-cnj/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-10-can-mounjaro-help-with-erectile-dysfunction-portal-cnj/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-10T08:51:07+01:00</news:publication_date><news:title>Can Mounjaro Help with Erectile Dysfunction? - Portal CNJ</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-10-eli-lilly-s-mounjaro-overtakes-keytruda-as-top-selling-drug/</loc><lastmod>2026-05-10T08:51:00+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-10-eli-lilly-s-mounjaro-overtakes-keytruda-as-top-selling-drug/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-10-eli-lilly-s-mounjaro-overtakes-keytruda-as-top-selling-drug/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-10T08:51:00+01:00</news:publication_date><news:title>Eli Lilly’s Mounjaro Overtakes Keytruda as Top-Selling Drug</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-10-fda-moves-to-remove-glp-1-medications-from-503b-bulks-list-m/</loc><lastmod>2026-05-10T08:50:52+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-10-fda-moves-to-remove-glp-1-medications-from-503b-bulks-list-m/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-10-fda-moves-to-remove-glp-1-medications-from-503b-bulks-list-m/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-10T08:50:52+01:00</news:publication_date><news:title>FDA moves to remove GLP-1 medications from 503B Bulks List - Medical News Today</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-09-eli-lilly-rises-on-fda-compounding-proposal/</loc><lastmod>2026-05-09T08:25:20+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-09-eli-lilly-rises-on-fda-compounding-proposal/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-09-eli-lilly-rises-on-fda-compounding-proposal/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-09T08:25:20+01:00</news:publication_date><news:title>Eli Lilly Rises on FDA Compounding Proposal</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-09-mounjaro-dethrones-keytruda-as-top-selling-global-drug/</loc><lastmod>2026-05-09T08:25:12+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-09-mounjaro-dethrones-keytruda-as-top-selling-global-drug/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-09-mounjaro-dethrones-keytruda-as-top-selling-global-drug/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-09T08:25:12+01:00</news:publication_date><news:title>Mounjaro dethrones Keytruda as top-selling global drug</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-09-stars-who-ve-spoken-about-ozempic-and-what-they-ve-said/</loc><lastmod>2026-05-09T08:25:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-09-stars-who-ve-spoken-about-ozempic-and-what-they-ve-said/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-09-stars-who-ve-spoken-about-ozempic-and-what-they-ve-said/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-09T08:25:06+01:00</news:publication_date><news:title>Stars Who've Spoken About Ozempic — and What They've Said</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-08-eli-lilly-s-mounjaro-becomes-world-s-top-selling-drug-the-bu/</loc><lastmod>2026-05-08T08:20:17+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-08-eli-lilly-s-mounjaro-becomes-world-s-top-selling-drug-the-bu/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-08-eli-lilly-s-mounjaro-becomes-world-s-top-selling-drug-the-bu/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-08T08:20:17+01:00</news:publication_date><news:title>Eli Lilly’s Mounjaro Becomes World’s Top-Selling Drug - The Business of Fashion</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-08-lilly-s-mounjaro-becomes-world-s-best-selling-drug-global-co/</loc><lastmod>2026-05-08T08:20:09+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-08-lilly-s-mounjaro-becomes-world-s-best-selling-drug-global-co/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-08-lilly-s-mounjaro-becomes-world-s-best-selling-drug-global-co/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-08T08:20:09+01:00</news:publication_date><news:title>Lilly’s Mounjaro becomes world’s best-selling drug - Global Cosmetics News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-08-mounjaro-sales-exceed-keytruda-in-q1-2026-tirzepatide-sales-/</loc><lastmod>2026-05-08T08:20:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-08-mounjaro-sales-exceed-keytruda-in-q1-2026-tirzepatide-sales-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-08-mounjaro-sales-exceed-keytruda-in-q1-2026-tirzepatide-sales-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-08T08:20:01+01:00</news:publication_date><news:title>Mounjaro Sales Exceed Keytruda in Q1 2026; Tirzepatide Sales Outpace Keytruda by $5 Billion in FY2025</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-07-dual-incretin-agonists-market-size-share-growth-report-2034-/</loc><lastmod>2026-05-07T09:28:53+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-07-dual-incretin-agonists-market-size-share-growth-report-2034-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-07-dual-incretin-agonists-market-size-share-growth-report-2034-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-07T09:28:53+01:00</news:publication_date><news:title>Dual Incretin Agonists Market Size, Share | Growth Report [2034] - Fortune Business Insights</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-07-lilly-s-mounjaro-overtakes-keytruda-as-world-s-top-selling-d/</loc><lastmod>2026-05-07T09:28:45+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-07-lilly-s-mounjaro-overtakes-keytruda-as-world-s-top-selling-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-07-lilly-s-mounjaro-overtakes-keytruda-as-world-s-top-selling-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-07T09:28:45+01:00</news:publication_date><news:title>Lilly’s Mounjaro overtakes Keytruda as world’s top-selling drug - The Boston Globe</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-07-lly-vs-novo-nordisk-2026-glp-1-stocks-compared/</loc><lastmod>2026-05-07T09:28:37+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-07-lly-vs-novo-nordisk-2026-glp-1-stocks-compared/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-07-lly-vs-novo-nordisk-2026-glp-1-stocks-compared/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-07T09:28:37+01:00</news:publication_date><news:title>LLY vs Novo Nordisk 2026: GLP-1 Stocks Compared</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-06-tirzepatide-tied-to-less-mortality-and-aes-than-semaglutide/</loc><lastmod>2026-05-06T09:21:27+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-06-tirzepatide-tied-to-less-mortality-and-aes-than-semaglutide/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-06-tirzepatide-tied-to-less-mortality-and-aes-than-semaglutide/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-06T09:21:27+01:00</news:publication_date><news:title>Tirzepatide Tied to Less Mortality and AEs Than Semaglutide</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-06-novo-nordisk-buoyed-by-outperforming-oral-wegovy-in-q1/</loc><lastmod>2026-05-06T09:21:18+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-06-novo-nordisk-buoyed-by-outperforming-oral-wegovy-in-q1/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-06-novo-nordisk-buoyed-by-outperforming-oral-wegovy-in-q1/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-06T09:21:18+01:00</news:publication_date><news:title>Novo Nordisk buoyed by outperforming oral Wegovy in Q1</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-06-glp-1-drug-savings-a-complete-guide-for-how-to-save-on-ozemp/</loc><lastmod>2026-05-06T09:21:10+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-06-glp-1-drug-savings-a-complete-guide-for-how-to-save-on-ozemp/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-06-glp-1-drug-savings-a-complete-guide-for-how-to-save-on-ozemp/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-06T09:21:10+01:00</news:publication_date><news:title>GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-05-france-fines-novo-nordisk-and-eli-lilly-over-ads-for-anti-ob/</loc><lastmod>2026-05-05T09:06:04+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-05-france-fines-novo-nordisk-and-eli-lilly-over-ads-for-anti-ob/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-05-france-fines-novo-nordisk-and-eli-lilly-over-ads-for-anti-ob/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-05T09:06:04+01:00</news:publication_date><news:title>France fines Novo Nordisk and Eli Lilly over ads for anti-obesity drugs - Le Monde.fr</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-05-next-gen-glp-1-leads-to-16-more-weight-loss-is-it-better-tha/</loc><lastmod>2026-05-05T09:05:53+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-05-next-gen-glp-1-leads-to-16-more-weight-loss-is-it-better-tha/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-05-next-gen-glp-1-leads-to-16-more-weight-loss-is-it-better-tha/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-05T09:05:53+01:00</news:publication_date><news:title>‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-05-obesity-meds-push-pharma-returns-higher-overtaking-oncology-/</loc><lastmod>2026-05-05T09:05:43+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-05-obesity-meds-push-pharma-returns-higher-overtaking-oncology-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-05-obesity-meds-push-pharma-returns-higher-overtaking-oncology-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-05T09:05:43+01:00</news:publication_date><news:title>Obesity meds push pharma returns higher, overtaking oncology: report - FirstWord Pharma</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-04-lilly-lowers-the-price-of-zepbound-tirzepatide-single-dose-v/</loc><lastmod>2026-05-04T09:15:19+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-04-lilly-lowers-the-price-of-zepbound-tirzepatide-single-dose-v/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-04-lilly-lowers-the-price-of-zepbound-tirzepatide-single-dose-v/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-04T09:15:19+01:00</news:publication_date><news:title>Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials | Eli Lilly and Company</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-04-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/</loc><lastmod>2026-05-04T09:15:11+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-04-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-04-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-04T09:15:11+01:00</news:publication_date><news:title>Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-03-eli-lilly-stock-jumps-on-earnings-beat-as-zepbound-and-mounj/</loc><lastmod>2026-05-03T08:44:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-03-eli-lilly-stock-jumps-on-earnings-beat-as-zepbound-and-mounj/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-03-eli-lilly-stock-jumps-on-earnings-beat-as-zepbound-and-mounj/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-03T08:44:44+01:00</news:publication_date><news:title>Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-03-fda-moves-to-permanently-close-the-door-on-compounded-glp-1s/</loc><lastmod>2026-05-03T08:44:36+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-03-fda-moves-to-permanently-close-the-door-on-compounded-glp-1s/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-03-fda-moves-to-permanently-close-the-door-on-compounded-glp-1s/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-03T08:44:36+01:00</news:publication_date><news:title>FDA Moves to Permanently Close the Door on Compounded GLP-1s - Pharmacy Times</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-02-price-pressure-on-weight-loss-drugs-slows-eli-lilly-s-growth/</loc><lastmod>2026-05-02T08:20:09+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-02-price-pressure-on-weight-loss-drugs-slows-eli-lilly-s-growth/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-02-price-pressure-on-weight-loss-drugs-slows-eli-lilly-s-growth/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-02T08:20:09+01:00</news:publication_date><news:title>Price pressure on weight-loss drugs slows Eli Lilly’s growth engine in the first quarter</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-02-fda-proposes-excluding-novo-lilly-weight-loss-drugs-from-bul/</loc><lastmod>2026-05-02T08:20:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-02-fda-proposes-excluding-novo-lilly-weight-loss-drugs-from-bul/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-02-fda-proposes-excluding-novo-lilly-weight-loss-drugs-from-bul/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-02T08:20:01+01:00</news:publication_date><news:title>FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-02-us-could-spend-1-trillion-on-medications-on-top-weight-loss-/</loc><lastmod>2026-05-02T08:19:53+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-02-us-could-spend-1-trillion-on-medications-on-top-weight-loss-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-02-us-could-spend-1-trillion-on-medications-on-top-weight-loss-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-02T08:19:53+01:00</news:publication_date><news:title>US could spend $1 trillion on medications. On top? Weight-loss drugs - The Detroit News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-01-fda-wants-to-limit-knockoff-versions-of-weight-loss-drugs-li/</loc><lastmod>2026-05-01T08:58:45+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-01-fda-wants-to-limit-knockoff-versions-of-weight-loss-drugs-li/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-01-fda-wants-to-limit-knockoff-versions-of-weight-loss-drugs-li/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-01T08:58:45+01:00</news:publication_date><news:title>FDA wants to limit knockoff versions of weight loss drugs like Ozempic and Zepbound - NBC News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-01-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/</loc><lastmod>2026-05-01T08:58:37+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-01-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-01-fake-mounjaro-in-india-eli-lilly-issues-tips-and-checklist-t/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-01T08:58:37+01:00</news:publication_date><news:title>Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-05-01-mounjaro-vs-ozempic-what-s-the-difference/</loc><lastmod>2026-05-01T08:58:27+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-05-01-mounjaro-vs-ozempic-what-s-the-difference/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-05-01-mounjaro-vs-ozempic-what-s-the-difference/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-05-01T08:58:27+01:00</news:publication_date><news:title>Mounjaro vs. Ozempic: What’s The Difference?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-30-tirzepatide-une-protection-cardiaque-inattendue-pour-ce-medi/</loc><lastmod>2026-04-30T09:09:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-30-tirzepatide-une-protection-cardiaque-inattendue-pour-ce-medi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-30-tirzepatide-une-protection-cardiaque-inattendue-pour-ce-medi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-30T09:09:44+01:00</news:publication_date><news:title>Tirzepatide : une protection cardiaque inattendue pour ce médicament déjà plébiscité</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-30-retatrutide-vs-tirzepatide-how-do-they-compare/</loc><lastmod>2026-04-30T09:09:36+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-30-retatrutide-vs-tirzepatide-how-do-they-compare/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-30-retatrutide-vs-tirzepatide-how-do-they-compare/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-30T09:09:36+01:00</news:publication_date><news:title>Retatrutide vs. Tirzepatide: How Do They Compare?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-29-new-research-reveals-possible-hidden-side-effects-of-glp-1-d/</loc><lastmod>2026-04-29T09:07:39+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-29-new-research-reveals-possible-hidden-side-effects-of-glp-1-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-29-new-research-reveals-possible-hidden-side-effects-of-glp-1-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-29T09:07:39+01:00</news:publication_date><news:title>New Research Reveals Possible Hidden Side Effects of GLP-1 Drugs - Health: Trusted and Empathetic Health and Wellness Information</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-29-system-is-broken-mounjaro-won-t-be-listed-on-pbs-in-stand-of/</loc><lastmod>2026-04-29T09:07:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-29-system-is-broken-mounjaro-won-t-be-listed-on-pbs-in-stand-of/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-29-system-is-broken-mounjaro-won-t-be-listed-on-pbs-in-stand-of/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-29T09:07:31+01:00</news:publication_date><news:title>'System … is broken': Mounjaro won't be listed on PBS in 'stand-off' with US maker - Australian Broadcasting Corporation</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-29-lly-earnings-glp-1-mounjaro-zepbound-read-through-for-your-p/</loc><lastmod>2026-04-29T09:07:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-29-lly-earnings-glp-1-mounjaro-zepbound-read-through-for-your-p/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-29-lly-earnings-glp-1-mounjaro-zepbound-read-through-for-your-p/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-29T09:07:23+01:00</news:publication_date><news:title>LLY Earnings: GLP-1, Mounjaro &amp; Zepbound Read-Through for Your Position</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-28-newsgp-mounjaro-manufacturer-rejects-pbs-recommendation-roya/</loc><lastmod>2026-04-28T09:18:52+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-28-newsgp-mounjaro-manufacturer-rejects-pbs-recommendation-roya/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-28-newsgp-mounjaro-manufacturer-rejects-pbs-recommendation-roya/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-28T09:18:52+01:00</news:publication_date><news:title>newsGP - Mounjaro manufacturer rejects PBS recommendation - Royal Australian College of General Practitioners (RACGP)</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-28-how-to-get-mounjaro-eligibility-criteria-and-where-to-buy/</loc><lastmod>2026-04-28T09:18:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-28-how-to-get-mounjaro-eligibility-criteria-and-where-to-buy/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-28-how-to-get-mounjaro-eligibility-criteria-and-where-to-buy/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-28T09:18:44+01:00</news:publication_date><news:title>How To Get Mounjaro: Eligibility Criteria And Where To Buy</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-28-glp-1-drugs-ozempic-preserves-muscle-mass-better-than-mounja/</loc><lastmod>2026-04-28T09:18:37+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-28-glp-1-drugs-ozempic-preserves-muscle-mass-better-than-mounja/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-28-glp-1-drugs-ozempic-preserves-muscle-mass-better-than-mounja/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-28T09:18:37+01:00</news:publication_date><news:title>GLP-1 Drugs: Ozempic Preserves Muscle Mass Better Than Mounjaro</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-27-popular-weight-loss-drug-may-cut-heart-attack-risk-by-54-new/</loc><lastmod>2026-04-27T09:19:39+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-27-popular-weight-loss-drug-may-cut-heart-attack-risk-by-54-new/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-27-popular-weight-loss-drug-may-cut-heart-attack-risk-by-54-new/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-27T09:19:39+01:00</news:publication_date><news:title>Popular Weight-Loss Drug May Cut Heart Attack Risk by 54%, New Studies Find</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-26-fake-mounjaro-row-accused-had-his-own-brand-toneup-the-times/</loc><lastmod>2026-04-26T08:14:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-26-fake-mounjaro-row-accused-had-his-own-brand-toneup-the-times/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-26-fake-mounjaro-row-accused-had-his-own-brand-toneup-the-times/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-26T08:14:31+01:00</news:publication_date><news:title>Fake Mounjaro row: Accused had his own brand, 'Toneup' - The Times of India</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-26-maker-of-mounjaro-warns-of-dangerous-chemical-reactions-in-k/</loc><lastmod>2026-04-26T08:14:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-26-maker-of-mounjaro-warns-of-dangerous-chemical-reactions-in-k/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-26-maker-of-mounjaro-warns-of-dangerous-chemical-reactions-in-k/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-26T08:14:23+01:00</news:publication_date><news:title>Maker of Mounjaro warns of dangerous 'chemical reactions' in knock-off versions of weight-loss drug</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-26-simple-metabolic-reset-found-to-prevent-weight-rebound-after/</loc><lastmod>2026-04-26T08:14:15+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-26-simple-metabolic-reset-found-to-prevent-weight-rebound-after/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-26-simple-metabolic-reset-found-to-prevent-weight-rebound-after/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-26T08:14:15+01:00</news:publication_date><news:title>Simple ‘metabolic reset’ found to prevent weight rebound after discontinuing GLP-1 drugs</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-25-the-best-glp-1-drug-on-the-market-is-even-better-than-we-kne/</loc><lastmod>2026-04-25T08:04:03+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-25-the-best-glp-1-drug-on-the-market-is-even-better-than-we-kne/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-25-the-best-glp-1-drug-on-the-market-is-even-better-than-we-kne/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-25T08:04:03+01:00</news:publication_date><news:title>The Best GLP-1 Drug on the Market Is Even Better Than We Knew</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-25-popular-weight-loss-drug-linked-to-key-benefits-for-patients/</loc><lastmod>2026-04-25T08:03:55+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-25-popular-weight-loss-drug-linked-to-key-benefits-for-patients/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-25-popular-weight-loss-drug-linked-to-key-benefits-for-patients/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-25T08:03:55+01:00</news:publication_date><news:title>Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI - Cardiovascular Business</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-25-mounjaro-zepbound-lowers-risk-of-cardiovascular-death-by-62/</loc><lastmod>2026-04-25T08:03:47+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-25-mounjaro-zepbound-lowers-risk-of-cardiovascular-death-by-62/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-25-mounjaro-zepbound-lowers-risk-of-cardiovascular-death-by-62/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-25T08:03:47+01:00</news:publication_date><news:title>Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62%</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-24-fake-mounjaro-probe-expands-beyond-ncr-after-seized-stock-tr/</loc><lastmod>2026-04-24T08:58:54+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-24-fake-mounjaro-probe-expands-beyond-ncr-after-seized-stock-tr/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-24-fake-mounjaro-probe-expands-beyond-ncr-after-seized-stock-tr/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-24T08:58:54+01:00</news:publication_date><news:title>Fake Mounjaro probe expands beyond NCR after seized stock traced to Hyderabad - The Times of India</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-24-simple-metabolic-reset-found-to-prevent-weight-rebound-after/</loc><lastmod>2026-04-24T08:58:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-24-simple-metabolic-reset-found-to-prevent-weight-rebound-after/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-24-simple-metabolic-reset-found-to-prevent-weight-rebound-after/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-24T08:58:44+01:00</news:publication_date><news:title>Simple ‘metabolic reset’ found to prevent weight rebound after discontinuing GLP-1 drugs</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-24-skinnyrx-glp-1-claims-evaluated-review-semaglutide-tirzepati/</loc><lastmod>2026-04-24T08:58:36+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-24-skinnyrx-glp-1-claims-evaluated-review-semaglutide-tirzepati/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-24-skinnyrx-glp-1-claims-evaluated-review-semaglutide-tirzepati/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-24T08:58:36+01:00</news:publication_date><news:title>SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide &amp; Tirzepatide Weight Loss Medication Options with Clinician-Guided Care</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-23-fda-issues-warning-letter-after-glp-1-manufacturer-refuses-i/</loc><lastmod>2026-04-23T08:51:18+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-23-fda-issues-warning-letter-after-glp-1-manufacturer-refuses-i/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-23-fda-issues-warning-letter-after-glp-1-manufacturer-refuses-i/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-23T08:51:18+01:00</news:publication_date><news:title>FDA issues warning letter after GLP-1 manufacturer refuses inspectors access</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-23-bdcda-issues-advisory-to-trade-fraternity-on-mounjaro-kwikpe/</loc><lastmod>2026-04-23T08:51:10+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-23-bdcda-issues-advisory-to-trade-fraternity-on-mounjaro-kwikpe/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-23-bdcda-issues-advisory-to-trade-fraternity-on-mounjaro-kwikpe/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-23T08:51:10+01:00</news:publication_date><news:title>BDCDA issues advisory to trade fraternity on Mounjaro KwikPen batches which are suspected to be counterfeit</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-23-lilly-s-suit-against-mounjaro-copies-advances-in-second-atte/</loc><lastmod>2026-04-23T08:51:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-23-lilly-s-suit-against-mounjaro-copies-advances-in-second-atte/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-23-lilly-s-suit-against-mounjaro-copies-advances-in-second-atte/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-23T08:51:01+01:00</news:publication_date><news:title>Lilly’s Suit Against Mounjaro Copies Advances in Second Attempt - Bloomberg Law News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-22-glp-1s-and-muscle-loss-ozempic-personality-acromegaly-and-ca/</loc><lastmod>2026-04-22T08:28:19+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-22-glp-1s-and-muscle-loss-ozempic-personality-acromegaly-and-ca/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-22-glp-1s-and-muscle-loss-ozempic-personality-acromegaly-and-ca/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-22T08:28:19+01:00</news:publication_date><news:title>GLP-1s and Muscle Loss; 'Ozempic Personality'; Acromegaly and Cancer Risk - MedPage Today</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-22-eli-lilly-can-proceed-with-lawsuit-against-telehealth-seller/</loc><lastmod>2026-04-22T08:28:09+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-22-eli-lilly-can-proceed-with-lawsuit-against-telehealth-seller/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-22-eli-lilly-can-proceed-with-lawsuit-against-telehealth-seller/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-22T08:28:09+01:00</news:publication_date><news:title>Eli Lilly can proceed with lawsuit against telehealth seller of weight-loss drugs - Courthouse News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-injections-racket-busted-in-gurugram-flat-two-/</loc><lastmod>2026-04-21T08:51:29+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-injections-racket-busted-in-gurugram-flat-two-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-injections-racket-busted-in-gurugram-flat-two-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-21T08:51:29+01:00</news:publication_date><news:title>Fake Mounjaro injections racket busted in Gurugram flat; two arrested, nationwide alert issued - Telegraph India</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-worth-rs-56-lakh-seized-in-gurugram-what-it-ca/</loc><lastmod>2026-04-21T08:51:21+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-worth-rs-56-lakh-seized-in-gurugram-what-it-ca/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-21-fake-mounjaro-worth-rs-56-lakh-seized-in-gurugram-what-it-ca/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-21T08:51:21+01:00</news:publication_date><news:title>Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-20-resultats-de-eli-lilly-les-ventes-internationales-de-tirzepa/</loc><lastmod>2026-04-20T09:06:35+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-20-resultats-de-eli-lilly-les-ventes-internationales-de-tirzepa/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-20-resultats-de-eli-lilly-les-ventes-internationales-de-tirzepa/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-20T09:06:35+01:00</news:publication_date><news:title>Résultats de Eli Lilly : les ventes internationales de tirzepatide ont dépassé nos prévisions.</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-20-rs-70-00-000-worth-fake-mounjaro-injections-seized-in-gurgao/</loc><lastmod>2026-04-20T09:06:27+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-20-rs-70-00-000-worth-fake-mounjaro-injections-seized-in-gurgao/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-20-rs-70-00-000-worth-fake-mounjaro-injections-seized-in-gurgao/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-20T09:06:27+01:00</news:publication_date><news:title>Rs 70,00,000 worth fake Mounjaro injections seized in Gurgaon; Police expose illegal weight-loss drug rack - The Economic Times</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-20-surmount-5-trial-tirzepatide-vs-semaglutide-in-obesity-manag/</loc><lastmod>2026-04-20T09:06:19+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-20-surmount-5-trial-tirzepatide-vs-semaglutide-in-obesity-manag/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-20-surmount-5-trial-tirzepatide-vs-semaglutide-in-obesity-manag/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-20T09:06:19+01:00</news:publication_date><news:title>SURMOUNT-5 Trial: Tirzepatide vs Semaglutide in Obesity Management - Medical Dialogues</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-19-l-ansm-muscle-son-jeu-face-a-la-vente-en-ligne-d-analogues-d/</loc><lastmod>2026-04-19T08:05:20+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-19-l-ansm-muscle-son-jeu-face-a-la-vente-en-ligne-d-analogues-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-19-l-ansm-muscle-son-jeu-face-a-la-vente-en-ligne-d-analogues-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-19T08:05:20+01:00</news:publication_date><news:title>L’ANSM muscle son jeu face à la vente en ligne d’analogues du GLP-1</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-19-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/</loc><lastmod>2026-04-19T08:05:11+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-19-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-19-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-19T08:05:11+01:00</news:publication_date><news:title>Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online - The Conversation</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-19-public-health-plans-should-cover-mounjaro-for-type-2-diabete/</loc><lastmod>2026-04-19T08:05:02+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-19-public-health-plans-should-cover-mounjaro-for-type-2-diabete/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-19-public-health-plans-should-cover-mounjaro-for-type-2-diabete/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-19T08:05:02+01:00</news:publication_date><news:title>Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends - The Globe and Mail</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-18-une-etude-revele-que-les-medicaments-amaigrissants-de-novo-p/</loc><lastmod>2026-04-18T07:58:34+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-18-une-etude-revele-que-les-medicaments-amaigrissants-de-novo-p/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-18-une-etude-revele-que-les-medicaments-amaigrissants-de-novo-p/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-18T07:58:34+01:00</news:publication_date><news:title>Une étude révèle que les médicaments amaigrissants de Novo pourraient mieux préserver la masse corporelle maig</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-18-study-looks-into-which-weight-loss-drug-makes-you-lose-the-m/</loc><lastmod>2026-04-18T07:58:26+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-18-study-looks-into-which-weight-loss-drug-makes-you-lose-the-m/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-18-study-looks-into-which-weight-loss-drug-makes-you-lose-the-m/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-18T07:58:26+01:00</news:publication_date><news:title>Study looks into which weight-loss drug makes you lose the most muscle - The Independent</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-18-can-ozempic-and-other-glp-1-drugs-reverse-type-2-diabetes-ev/</loc><lastmod>2026-04-18T07:58:17+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-18-can-ozempic-and-other-glp-1-drugs-reverse-type-2-diabetes-ev/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-18-can-ozempic-and-other-glp-1-drugs-reverse-type-2-diabetes-ev/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-18T07:58:17+01:00</news:publication_date><news:title>Can Ozempic and Other GLP-1 Drugs Reverse Type 2 Diabetes? - Everyday Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-17-what-happens-when-you-stop-ozempic-or-mounjaro-new-study-rev/</loc><lastmod>2026-04-17T08:25:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-17-what-happens-when-you-stop-ozempic-or-mounjaro-new-study-rev/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-17-what-happens-when-you-stop-ozempic-or-mounjaro-new-study-rev/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-17T08:25:31+01:00</news:publication_date><news:title>What Happens When You Stop Ozempic or Mounjaro? New Study Reveals Surprising Weight-Loss Results - Muscle &amp; Fitness</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-17-novo-weight-loss-drug-may-preserve-lean-body-mass-better-tha/</loc><lastmod>2026-04-17T08:25:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-17-novo-weight-loss-drug-may-preserve-lean-body-mass-better-tha/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-17-novo-weight-loss-drug-may-preserve-lean-body-mass-better-tha/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-17T08:25:23+01:00</news:publication_date><news:title>Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-17-ozempic-might-preserve-lean-body-mass-better-than-mounjaro-s/</loc><lastmod>2026-04-17T08:25:16+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-17-ozempic-might-preserve-lean-body-mass-better-than-mounjaro-s/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-17-ozempic-might-preserve-lean-body-mass-better-than-mounjaro-s/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-17T08:25:16+01:00</news:publication_date><news:title>Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-16-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/</loc><lastmod>2026-04-16T08:26:08+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-16-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-16-ads-for-glp-1-drugs-are-flooding-the-internet-here-s-how-to-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-16T08:26:08+01:00</news:publication_date><news:title>Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online - Citizen Tribune</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-16-the-glp-1-era-how-weight-loss-medications-are-rewriting-our-/</loc><lastmod>2026-04-16T08:25:59+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-16-the-glp-1-era-how-weight-loss-medications-are-rewriting-our-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-16-the-glp-1-era-how-weight-loss-medications-are-rewriting-our-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-16T08:25:59+01:00</news:publication_date><news:title>The GLP-1 Era: How Weight Loss Medications Are Rewriting Our Ideas of Health, Discipline, and Body Image</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-16-glp-1s-are-busting-employer-budgets-some-are-getting-creativ/</loc><lastmod>2026-04-16T08:25:50+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-16-glp-1s-are-busting-employer-budgets-some-are-getting-creativ/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-16-glp-1s-are-busting-employer-budgets-some-are-getting-creativ/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-16T08:25:50+01:00</news:publication_date><news:title>GLP-1s Are Busting Employer Budgets. Some Are Getting Creative to Lower Costs.</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-15-popular-weight-loss-medications-linked-to-hidden-side-effect/</loc><lastmod>2026-04-15T08:26:57+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-15-popular-weight-loss-medications-linked-to-hidden-side-effect/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-15-popular-weight-loss-medications-linked-to-hidden-side-effect/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-15T08:26:57+01:00</news:publication_date><news:title>Popular weight-loss medications linked to hidden side effects, study finds</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-15-generics-play-an-important-role-eli-lilly-on-glp-1-competiti/</loc><lastmod>2026-04-15T08:26:49+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-15-generics-play-an-important-role-eli-lilly-on-glp-1-competiti/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-15-generics-play-an-important-role-eli-lilly-on-glp-1-competiti/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-15T08:26:49+01:00</news:publication_date><news:title>"Generics Play an Important Role”: Eli Lilly on GLP-1 Competition - Forbes India</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-15-mounjaro-approved-for-use-in-children-in-uk-in-significant-a/</loc><lastmod>2026-04-15T08:26:41+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-15-mounjaro-approved-for-use-in-children-in-uk-in-significant-a/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-15-mounjaro-approved-for-use-in-children-in-uk-in-significant-a/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-15T08:26:41+01:00</news:publication_date><news:title>Mounjaro approved for use in children in UK in ‘significant advance in paediatric care’ - The Pharmaceutical Journal</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-14-thinking-about-a-glp-1-drug-your-genetics-might-determine-ho/</loc><lastmod>2026-04-14T08:24:59+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-14-thinking-about-a-glp-1-drug-your-genetics-might-determine-ho/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-14-thinking-about-a-glp-1-drug-your-genetics-might-determine-ho/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-14T08:24:59+01:00</news:publication_date><news:title>Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare - U.S. News &amp; World Report</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-14-why-some-people-lose-more-weight-on-glp-1-drugs/</loc><lastmod>2026-04-14T08:24:51+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-14-why-some-people-lose-more-weight-on-glp-1-drugs/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-14-why-some-people-lose-more-weight-on-glp-1-drugs/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-14T08:24:51+01:00</news:publication_date><news:title>Why some people lose more weight on GLP-1 drugs</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-13-cheaper-generics-capture-20-of-weight-loss-mkt-the-times-of-/</loc><lastmod>2026-04-13T09:00:00+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-13-cheaper-generics-capture-20-of-weight-loss-mkt-the-times-of-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-13-cheaper-generics-capture-20-of-weight-loss-mkt-the-times-of-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-13T09:00:00+01:00</news:publication_date><news:title>Cheaper generics capture 20% of weight-loss mkt - The Times of India</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-13-not-losing-weight-on-mounjaro-or-ozempic-your-genes-could-be/</loc><lastmod>2026-04-13T08:59:51+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-13-not-losing-weight-on-mounjaro-or-ozempic-your-genes-could-be/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-13-not-losing-weight-on-mounjaro-or-ozempic-your-genes-could-be/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-13T08:59:51+01:00</news:publication_date><news:title>Not losing weight on Mounjaro or Ozempic? Your genes could be the reason, says new study - The Indian Express</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-13-ozempic-vs-mounjaro-what-india-s-first-real-world-study-says/</loc><lastmod>2026-04-13T08:59:43+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-13-ozempic-vs-mounjaro-what-india-s-first-real-world-study-says/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-13-ozempic-vs-mounjaro-what-india-s-first-real-world-study-says/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-13T08:59:43+01:00</news:publication_date><news:title>Ozempic vs Mounjaro: What India’s first real-world study says, and why the timing matters - The South First</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-12-health-rounds-variations-genetiques-liees-a-la-perte-de-poid/</loc><lastmod>2026-04-12T08:01:48+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-12-health-rounds-variations-genetiques-liees-a-la-perte-de-poid/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-12-health-rounds-variations-genetiques-liees-a-la-perte-de-poid/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-12T08:01:48+01:00</news:publication_date><news:title>Health Rounds : Variations génétiques liées à la perte de poids et aux effets secondaires des médicaments GLP-</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-12-mounjaro-monthly-sales-drop-for-first-time-in-march-semaglut/</loc><lastmod>2026-04-12T08:01:42+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-12-mounjaro-monthly-sales-drop-for-first-time-in-march-semaglut/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-12-mounjaro-monthly-sales-drop-for-first-time-in-march-semaglut/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-12T08:01:42+01:00</news:publication_date><news:title>Mounjaro monthly sales drop for first time in March, semaglutide gains volume</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-11-unlocking-the-genetics-of-glp-1-medications-why-your-dna-mat/</loc><lastmod>2026-04-11T07:48:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-11-unlocking-the-genetics-of-glp-1-medications-why-your-dna-mat/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-11-unlocking-the-genetics-of-glp-1-medications-why-your-dna-mat/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-11T07:48:06+01:00</news:publication_date><news:title>Unlocking the Genetics of GLP-1 Medications: Why Your DNA Matters - 23andMe Blog</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-11-pharma-50-keytruda-holds-the-top-brand-slot-but-tirzepatide-/</loc><lastmod>2026-04-11T07:47:58+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-11-pharma-50-keytruda-holds-the-top-brand-slot-but-tirzepatide-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-11-pharma-50-keytruda-holds-the-top-brand-slot-but-tirzepatide-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-11T07:47:58+01:00</news:publication_date><news:title>Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-11-glp-1-weight-loss-side-effects-linked-to-genetic-variations/</loc><lastmod>2026-04-11T07:47:49+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-11-glp-1-weight-loss-side-effects-linked-to-genetic-variations/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-11-glp-1-weight-loss-side-effects-linked-to-genetic-variations/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-11T07:47:49+01:00</news:publication_date><news:title>GLP-1 weight loss, side effects linked to genetic variations</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-10-evidence-excitement-in-the-moment-with-a-glp-1-expert-uw-med/</loc><lastmod>2026-04-10T08:20:37+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-10-evidence-excitement-in-the-moment-with-a-glp-1-expert-uw-med/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-10-evidence-excitement-in-the-moment-with-a-glp-1-expert-uw-med/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-10T08:20:37+01:00</news:publication_date><news:title>Evidence, excitement: In the moment with a GLP-1 expert - UW Medicine | Newsroom</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-10-tirzepatide-outperforms-dulaglutide-on-cardiorenal-outcomes-/</loc><lastmod>2026-04-10T08:20:27+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-10-tirzepatide-outperforms-dulaglutide-on-cardiorenal-outcomes-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-10-tirzepatide-outperforms-dulaglutide-on-cardiorenal-outcomes-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-10T08:20:27+01:00</news:publication_date><news:title>Tirzepatide Outperforms Dulaglutide on Cardiorenal Outcomes in High-Risk Diabetes - The American Journal of Managed Care® (AJMC®)</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-10-pharmacists-play-central-role-in-optimizing-tirzepatide-use-/</loc><lastmod>2026-04-10T08:20:17+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-10-pharmacists-play-central-role-in-optimizing-tirzepatide-use-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-10-pharmacists-play-central-role-in-optimizing-tirzepatide-use-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-10T08:20:17+01:00</news:publication_date><news:title>Pharmacists Play Central Role in Optimizing Tirzepatide Use for Type 2 Diabetes - Pharmacy Times</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-09-ozempic-weight-loss-success-varies-by-dna-neuroscience-news/</loc><lastmod>2026-04-09T08:19:24+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-09-ozempic-weight-loss-success-varies-by-dna-neuroscience-news/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-09-ozempic-weight-loss-success-varies-by-dna-neuroscience-news/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-09T08:19:24+01:00</news:publication_date><news:title>Ozempic Weight Loss Success Varies by DNA - Neuroscience News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-09-if-you-aren-t-losing-weight-with-glp-1-drugs-this-may-be-one/</loc><lastmod>2026-04-09T08:19:16+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-09-if-you-aren-t-losing-weight-with-glp-1-drugs-this-may-be-one/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-09-if-you-aren-t-losing-weight-with-glp-1-drugs-this-may-be-one/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-09T08:19:16+01:00</news:publication_date><news:title>If you aren’t losing weight with GLP-1 drugs, this may be one reason why - The Boston Globe</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-09-weight-loss-drugs-who-benefits-most-and-why/</loc><lastmod>2026-04-09T08:19:08+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-09-weight-loss-drugs-who-benefits-most-and-why/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-09-weight-loss-drugs-who-benefits-most-and-why/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-09T08:19:08+01:00</news:publication_date><news:title>Weight-loss drugs: Who benefits most and why?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-08-mounjaro-slimming-syringe-reuters-connect/</loc><lastmod>2026-04-08T08:12:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-08-mounjaro-slimming-syringe-reuters-connect/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-08-mounjaro-slimming-syringe-reuters-connect/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-08T08:12:01+01:00</news:publication_date><news:title>Mounjaro slimming syringe - Reuters Connect</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-08-weight-loss-after-tirzepatide-varies-by-prior-weight-change/</loc><lastmod>2026-04-08T08:11:53+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-08-weight-loss-after-tirzepatide-varies-by-prior-weight-change/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-08-weight-loss-after-tirzepatide-varies-by-prior-weight-change/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-08T08:11:53+01:00</news:publication_date><news:title>Weight Loss After Tirzepatide Varies by Prior Weight Change</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-07-9-mounjaro-alternatives-for-weight-loss-and-diabetes/</loc><lastmod>2026-04-07T08:11:39+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-07-9-mounjaro-alternatives-for-weight-loss-and-diabetes/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-07-9-mounjaro-alternatives-for-weight-loss-and-diabetes/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-07T08:11:39+01:00</news:publication_date><news:title>9 Mounjaro Alternatives for Weight Loss and Diabetes</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-07-can-mounjaro-make-birth-control-less-effective-medshadow-fou/</loc><lastmod>2026-04-07T08:11:30+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-07-can-mounjaro-make-birth-control-less-effective-medshadow-fou/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-07-can-mounjaro-make-birth-control-less-effective-medshadow-fou/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-07T08:11:30+01:00</news:publication_date><news:title>Can Mounjaro Make Birth Control Less Effective? - MedShadow Foundation</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-07-scientists-uncover-new-metabolic-effects-beyond-weight-loss-/</loc><lastmod>2026-04-07T08:11:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-07-scientists-uncover-new-metabolic-effects-beyond-weight-loss-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-07-scientists-uncover-new-metabolic-effects-beyond-weight-loss-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-07T08:11:23+01:00</news:publication_date><news:title>Scientists Uncover New Metabolic Effects Beyond Weight Loss of Mounjaro</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-06-actualite-analogues-du-glp-1-indiques-dans-le-traitement-de-/</loc><lastmod>2026-04-06T08:21:48+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-06-actualite-analogues-du-glp-1-indiques-dans-le-traitement-de-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-06-actualite-analogues-du-glp-1-indiques-dans-le-traitement-de-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-06T08:21:48+01:00</news:publication_date><news:title>Actualité - Analogues du GLP-1 indiqués dans le traitement de l’obésité : l’ANSM fait évoluer leurs conditions de prescription et de délivrance</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-06-9-foundayo-orforglipron-side-effects-you-should-know-about/</loc><lastmod>2026-04-06T08:21:39+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-06-9-foundayo-orforglipron-side-effects-you-should-know-about/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-06-9-foundayo-orforglipron-side-effects-you-should-know-about/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-06T08:21:39+01:00</news:publication_date><news:title>9 Foundayo (Orforglipron) Side Effects You Should Know About</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-06-mounjaro-slimming-syringe-reuters-connect/</loc><lastmod>2026-04-06T08:21:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-06-mounjaro-slimming-syringe-reuters-connect/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-06-mounjaro-slimming-syringe-reuters-connect/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-06T08:21:31+01:00</news:publication_date><news:title>Mounjaro slimming syringe - Reuters Connect</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-05-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/</loc><lastmod>2026-04-05T07:53:40+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-05-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-05-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-05T07:53:40+01:00</news:publication_date><news:title>Lilly découvre une impureté dans une version composée de son médicament pour la perte de poids et met en garde</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-04-joi-blokes-compounded-glp-1-review-2026-semaglutide-tirzepat/</loc><lastmod>2026-04-04T07:47:30+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-04-joi-blokes-compounded-glp-1-review-2026-semaglutide-tirzepat/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-04-joi-blokes-compounded-glp-1-review-2026-semaglutide-tirzepat/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-04T07:47:30+01:00</news:publication_date><news:title>Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-04-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/</loc><lastmod>2026-04-04T07:47:21+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-04-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-04-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-04T07:47:21+01:00</news:publication_date><news:title>Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes - Eli Lilly</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-03-fda-approves-foundayo-eli-lilly-s-new-glp-1-obesity-pill-liv/</loc><lastmod>2026-04-03T08:01:08+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-03-fda-approves-foundayo-eli-lilly-s-new-glp-1-obesity-pill-liv/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-03-fda-approves-foundayo-eli-lilly-s-new-glp-1-obesity-pill-liv/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-03T08:01:08+01:00</news:publication_date><news:title>FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill - LiveNOW from FOX</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-03-tirzepatide-effective-despite-weight-inducing-meds/</loc><lastmod>2026-04-03T08:00:59+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-03-tirzepatide-effective-despite-weight-inducing-meds/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-03-tirzepatide-effective-despite-weight-inducing-meds/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-03T08:00:59+01:00</news:publication_date><news:title>Tirzepatide Effective Despite Weight-Inducing Meds</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-02-a-second-weight-loss-pill-just-hit-the-market-here-s-how-it-/</loc><lastmod>2026-04-02T08:05:45+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-02-a-second-weight-loss-pill-just-hit-the-market-here-s-how-it-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-02-a-second-weight-loss-pill-just-hit-the-market-here-s-how-it-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-02T08:05:45+01:00</news:publication_date><news:title>A Second Weight Loss Pill Just Hit the Market. Here’s How It’s Different. - Men's Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-02-with-an-fda-nod-lilly-s-oral-glp-1-enters-the-obesity-ring-a/</loc><lastmod>2026-04-02T08:05:36+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-02-with-an-fda-nod-lilly-s-oral-glp-1-enters-the-obesity-ring-a/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-02-with-an-fda-nod-lilly-s-oral-glp-1-enters-the-obesity-ring-a/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-02T08:05:36+01:00</news:publication_date><news:title>With an FDA nod, Lilly's oral GLP-1 enters the obesity ring as Foundayo - FirstWord Pharma</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-02-fda-approves-eli-lilly-s-obesity-pill-foundayo-time-magazine/</loc><lastmod>2026-04-02T08:05:28+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-02-fda-approves-eli-lilly-s-obesity-pill-foundayo-time-magazine/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-02-fda-approves-eli-lilly-s-obesity-pill-foundayo-time-magazine/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-02T08:05:28+01:00</news:publication_date><news:title>FDA Approves Eli Lilly's Obesity Pill, Foundayo - Time Magazine</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-04-01-cardiovascular-outcomes-with-tirzepatide-versus-dulaglutide-/</loc><lastmod>2026-04-01T08:14:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-04-01-cardiovascular-outcomes-with-tirzepatide-versus-dulaglutide-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-04-01-cardiovascular-outcomes-with-tirzepatide-versus-dulaglutide-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-04-01T08:14:44+01:00</news:publication_date><news:title>Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-31-beyond-diabetes-control-tirzepatide-boosts-quality-of-life/</loc><lastmod>2026-03-31T08:07:03+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-31-beyond-diabetes-control-tirzepatide-boosts-quality-of-life/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-31-beyond-diabetes-control-tirzepatide-boosts-quality-of-life/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-31T08:07:03+01:00</news:publication_date><news:title>Beyond Diabetes Control: Tirzepatide Boosts Quality of Life</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-30-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/</loc><lastmod>2026-03-30T08:21:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-30-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-30-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-30T08:21:06+01:00</news:publication_date><news:title>Eli Lilly continue à prendre de l'embonpoint, sur un marché de plus en plus concurrentiel - Les Echos</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-30-allurion-announces-partnership-to-offer-combination-therapy-/</loc><lastmod>2026-03-30T08:20:57+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-30-allurion-announces-partnership-to-offer-combination-therapy-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-30-allurion-announces-partnership-to-offer-combination-therapy-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-30T08:20:57+01:00</news:publication_date><news:title>Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Business Wire</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-30-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/</loc><lastmod>2026-03-30T08:20:49+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-30-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-30-lilly-s-mounjaro-tirzepatide-a-gip-glp-1-dual-receptor-agoni/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-30T08:20:49+01:00</news:publication_date><news:title>Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes - PR Newswire</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-28-opinion-taking-ozempic-or-other-glp-1-drugs-isn-t-cheating/</loc><lastmod>2026-03-28T21:48:20+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-28-opinion-taking-ozempic-or-other-glp-1-drugs-isn-t-cheating/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-28-opinion-taking-ozempic-or-other-glp-1-drugs-isn-t-cheating/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-28T21:48:20+01:00</news:publication_date><news:title>Opinion | Taking Ozempic (or other GLP-1 drugs) isn’t cheating</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-28-vanessa-williams-has-had-a-striking-transformation-thanks-to/</loc><lastmod>2026-03-28T21:48:13+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-28-vanessa-williams-has-had-a-striking-transformation-thanks-to/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-28-vanessa-williams-has-had-a-striking-transformation-thanks-to/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-28T21:48:13+01:00</news:publication_date><news:title>Vanessa Williams Has Had A Striking Transformation Thanks To Mounjaro</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-28-tirzepatide-associated-with-lower-risk-of-heart-and-kidney-d/</loc><lastmod>2026-03-28T21:48:05+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-28-tirzepatide-associated-with-lower-risk-of-heart-and-kidney-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-28-tirzepatide-associated-with-lower-risk-of-heart-and-kidney-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-28T21:48:05+01:00</news:publication_date><news:title>Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease - Cleveland Clinic Newsroom</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-28-13-surprising-ways-glp-1s-may-benefit-the-body-according-to-/</loc><lastmod>2026-03-28T07:43:08+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-28-13-surprising-ways-glp-1s-may-benefit-the-body-according-to-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-28-13-surprising-ways-glp-1s-may-benefit-the-body-according-to-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-28T07:43:08+01:00</news:publication_date><news:title>13 surprising ways GLP-1s may benefit the body, according to science - The Washington Post</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-28-glp-1-agonists-could-be-a-global-game-changer-but-need-to-be/</loc><lastmod>2026-03-28T07:43:00+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-28-glp-1-agonists-could-be-a-global-game-changer-but-need-to-be/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-28-glp-1-agonists-could-be-a-global-game-changer-but-need-to-be/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-28T07:43:00+01:00</news:publication_date><news:title>GLP-1 agonists could be a global game-changer, but need to be accessible and affordable</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-27-traitement-de-l-obesite-la-chirurgie-fait-mieux-que-les-medi/</loc><lastmod>2026-03-27T07:58:59+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-27-traitement-de-l-obesite-la-chirurgie-fait-mieux-que-les-medi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-27-traitement-de-l-obesite-la-chirurgie-fait-mieux-que-les-medi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-27T07:58:59+01:00</news:publication_date><news:title>Traitement de l’obésité La chirurgie fait mieux que les médicaments tels que Wegovy et Mounjaro - UFC-Que Choisir</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-27-orforglipron-vs-tirzepatide-weight-loss-pill-vs-injection/</loc><lastmod>2026-03-27T07:58:52+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-27-orforglipron-vs-tirzepatide-weight-loss-pill-vs-injection/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-27-orforglipron-vs-tirzepatide-weight-loss-pill-vs-injection/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-27T07:58:52+01:00</news:publication_date><news:title>Orforglipron vs. Tirzepatide: Weight Loss Pill vs. Injection</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-27-why-tirzepatide-is-better-than-semaglutide-glp-1-medication-/</loc><lastmod>2026-03-27T07:58:43+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-27-why-tirzepatide-is-better-than-semaglutide-glp-1-medication-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-27-why-tirzepatide-is-better-than-semaglutide-glp-1-medication-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-27T07:58:43+01:00</news:publication_date><news:title>Why tirzepatide is better than semaglutide, GLP-1 medication guide - USA Today</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-26-ce-duo-de-traitement-a-permis-a-120-femmes-de-perdre-35-de-p/</loc><lastmod>2026-03-26T08:01:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-26-ce-duo-de-traitement-a-permis-a-120-femmes-de-perdre-35-de-p/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-26-ce-duo-de-traitement-a-permis-a-120-femmes-de-perdre-35-de-p/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-26T08:01:06+01:00</news:publication_date><news:title>Ce duo de traitement a permis à 120 femmes de perdre 35 % de poids en plus à la ménopause - Top Santé</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-26-weight-gain-fears-after-stopping-ozempic-unfounded-cleveland/</loc><lastmod>2026-03-26T08:00:57+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-26-weight-gain-fears-after-stopping-ozempic-unfounded-cleveland/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-26-weight-gain-fears-after-stopping-ozempic-unfounded-cleveland/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-26T08:00:57+01:00</news:publication_date><news:title>Weight-gain fears after stopping Ozempic unfounded – Cleveland Clinic study - Medical Brief</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-26-improved-heart-and-kidney-outcomes-for-type-1-diabetes-patie/</loc><lastmod>2026-03-26T08:00:48+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-26-improved-heart-and-kidney-outcomes-for-type-1-diabetes-patie/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-26-improved-heart-and-kidney-outcomes-for-type-1-diabetes-patie/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-26T08:00:48+01:00</news:publication_date><news:title>Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs - Johns Hopkins Bloomberg School of Public Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-24-stopping-glp-1-drugs-may-raise-heart-risks/</loc><lastmod>2026-03-24T07:52:30+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-24-stopping-glp-1-drugs-may-raise-heart-risks/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-24-stopping-glp-1-drugs-may-raise-heart-risks/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-24T07:52:30+01:00</news:publication_date><news:title>Stopping GLP-1 Drugs May Raise Heart Risks</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-24-india-s-drug-regulator-tightens-surveillance-against-unautho/</loc><lastmod>2026-03-24T07:52:22+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-24-india-s-drug-regulator-tightens-surveillance-against-unautho/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-24-india-s-drug-regulator-tightens-surveillance-against-unautho/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-24T07:52:22+01:00</news:publication_date><news:title>India's drug regulator tightens surveillance against unauthorized weight-loss drug sales</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-23-eli-lilly-and-company-lly-expands-zepbound-access-as-pricing/</loc><lastmod>2026-03-23T08:01:10+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-23-eli-lilly-and-company-lly-expands-zepbound-access-as-pricing/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-23-eli-lilly-and-company-lly-expands-zepbound-access-as-pricing/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-23T08:01:10+01:00</news:publication_date><news:title>Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook - Yahoo! Finance Canada</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-23-beyond-the-weight-loss-injection-how-this-44-year-old-balanc/</loc><lastmod>2026-03-23T08:01:02+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-23-beyond-the-weight-loss-injection-how-this-44-year-old-balanc/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-23-beyond-the-weight-loss-injection-how-this-44-year-old-balanc/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-23T08:01:02+01:00</news:publication_date><news:title>Beyond the weight-loss injection: How this 44-year-old balances Mounjaro with diet, exercise and sleep - The Indian Express</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-22-mounjaro-le-traitement-minceur-qui-augmente-la-poitrine-effe/</loc><lastmod>2026-03-22T07:36:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-22-mounjaro-le-traitement-minceur-qui-augmente-la-poitrine-effe/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-22-mounjaro-le-traitement-minceur-qui-augmente-la-poitrine-effe/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-22T07:36:44+01:00</news:publication_date><news:title>Mounjaro : le traitement minceur qui augmente la poitrine ? Effets secondaires et explications</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-22-generic-semaglutide-in-india-and-other-weight-loss-news/</loc><lastmod>2026-03-22T07:36:38+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-22-generic-semaglutide-in-india-and-other-weight-loss-news/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-22-generic-semaglutide-in-india-and-other-weight-loss-news/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-22T07:36:38+01:00</news:publication_date><news:title>Generic semaglutide in India, and other weight-loss news</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-22-weight-loss-drugs-in-india-ozempic-and-wegovy-alternatives-e/</loc><lastmod>2026-03-22T07:36:29+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-22-weight-loss-drugs-in-india-ozempic-and-wegovy-alternatives-e/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-22-weight-loss-drugs-in-india-ozempic-and-wegovy-alternatives-e/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-22T07:36:29+01:00</news:publication_date><news:title>Weight Loss Drugs in India: Ozempic and Wegovy Alternatives, Explained - Open Magazine</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-21-early-use-of-tirzepatide-after-heart-attack-or-stroke-linked/</loc><lastmod>2026-03-21T07:56:00+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-21-early-use-of-tirzepatide-after-heart-attack-or-stroke-linked/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-21-early-use-of-tirzepatide-after-heart-attack-or-stroke-linked/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-21T07:56:00+01:00</news:publication_date><news:title>Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits - Cardiovascular Business</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-21-heart-benefits-from-glp-1-drugs-fade-after-stopping-study-fi/</loc><lastmod>2026-03-21T07:55:52+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-21-heart-benefits-from-glp-1-drugs-fade-after-stopping-study-fi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-21-heart-benefits-from-glp-1-drugs-fade-after-stopping-study-fi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-21T07:55:52+01:00</news:publication_date><news:title>Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds - U.S. News &amp; World Report</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-21-glp-1-vision-loss-lawsuits-ozempic-wegovy-and-naion-optic-ne/</loc><lastmod>2026-03-21T07:55:44+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-21-glp-1-vision-loss-lawsuits-ozempic-wegovy-and-naion-optic-ne/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-21-glp-1-vision-loss-lawsuits-ozempic-wegovy-and-naion-optic-ne/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-21T07:55:44+01:00</news:publication_date><news:title>GLP-1 Vision Loss Lawsuits: Ozempic, Wegovy, and NAION Optic Nerve Injury Claims - JD Supra</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-20-lilly-s-triple-g-agonist-succeeds-in-phase-iii-diabetes-tria/</loc><lastmod>2026-03-20T09:05:32+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-20-lilly-s-triple-g-agonist-succeeds-in-phase-iii-diabetes-tria/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-20-lilly-s-triple-g-agonist-succeeds-in-phase-iii-diabetes-tria/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-20T09:05:32+01:00</news:publication_date><news:title>Lilly’s triple G agonist succeeds in Phase III diabetes trial - Clinical Trials Arena</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-20-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/</loc><lastmod>2026-03-20T09:05:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-20-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-20-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-20T09:05:23+01:00</news:publication_date><news:title>Stopping GLP-1 drugs can quickly erase cardiovascular benefits - WashU Medicine</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-20-what-happens-after-ozempic-shocked-researchers/</loc><lastmod>2026-03-20T09:05:15+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-20-what-happens-after-ozempic-shocked-researchers/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-20-what-happens-after-ozempic-shocked-researchers/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-20T09:05:15+01:00</news:publication_date><news:title>What happens after Ozempic shocked researchers</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-19-why-did-eli-lilly-stock-slide-6-despite-strong-glp-1-momentu/</loc><lastmod>2026-03-19T09:11:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-19-why-did-eli-lilly-stock-slide-6-despite-strong-glp-1-momentu/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-19-why-did-eli-lilly-stock-slide-6-despite-strong-glp-1-momentu/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-19T09:11:31+01:00</news:publication_date><news:title>Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-19-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/</loc><lastmod>2026-03-19T09:11:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-19-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-19-stopping-glp-1-drugs-can-quickly-erase-cardiovascular-benefi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-19T09:11:23+01:00</news:publication_date><news:title>Stopping GLP-1 drugs can quickly erase cardiovascular benefits - Medical Xpress</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-19-semaglutide-vs-tirzepatide-for-weight-loss-us-news-health/</loc><lastmod>2026-03-19T09:11:15+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-19-semaglutide-vs-tirzepatide-for-weight-loss-us-news-health/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-19-semaglutide-vs-tirzepatide-for-weight-loss-us-news-health/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-19T09:11:15+01:00</news:publication_date><news:title>Semaglutide vs. Tirzepatide for Weight Loss - US News Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-17-un-medicament-contre-l-obesite-permet-de-perdre-jusqu-a-20-d/</loc><lastmod>2026-03-17T10:10:48+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-17-un-medicament-contre-l-obesite-permet-de-perdre-jusqu-a-20-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-17-un-medicament-contre-l-obesite-permet-de-perdre-jusqu-a-20-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-17T10:10:48+01:00</news:publication_date><news:title>Un médicament contre l’obésité permet de perdre jusqu’à 20 % du poids, mais son arrêt inquiète les médecins - Science et vie</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-16-what-happens-when-patients-stop-taking-glp-1-drugs-new-cleve/</loc><lastmod>2026-03-16T10:37:17+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-16-what-happens-when-patients-stop-taking-glp-1-drugs-new-cleve/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-16-what-happens-when-patients-stop-taking-glp-1-drugs-new-cleve/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-16T10:37:17+01:00</news:publication_date><news:title>What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights - Cleveland Clinic Newsroom</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-15-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/</loc><lastmod>2026-03-15T08:04:11+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-15-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-15-lilly-decouvre-une-impurete-dans-une-version-composee-de-son/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-15T08:04:11+01:00</news:publication_date><news:title>Lilly découvre une impureté dans une version composée de son médicament pour la perte de poids et met en garde</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-15-compounded-version-of-eli-lilly-glp-1-may-have-impurity-comp/</loc><lastmod>2026-03-15T08:04:02+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-15-compounded-version-of-eli-lilly-glp-1-may-have-impurity-comp/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-15-compounded-version-of-eli-lilly-glp-1-may-have-impurity-comp/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-15T08:04:02+01:00</news:publication_date><news:title>Compounded version of Eli Lilly GLP-1 may have impurity, company warns</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-15-why-compounded-mounjaro-may-be-riskier-than-you-think-especi/</loc><lastmod>2026-03-15T08:03:54+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-15-why-compounded-mounjaro-may-be-riskier-than-you-think-especi/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-15-why-compounded-mounjaro-may-be-riskier-than-you-think-especi/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-15T08:03:54+01:00</news:publication_date><news:title>Why compounded Mounjaro may be riskier than you think, especially if it contains B12 - The South First</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-14-lilly-says-compounded-tirzepatide-with-added-vitamin-b12-con/</loc><lastmod>2026-03-14T07:59:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-14-lilly-says-compounded-tirzepatide-with-added-vitamin-b12-con/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-14-lilly-says-compounded-tirzepatide-with-added-vitamin-b12-con/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-14T07:59:01+01:00</news:publication_date><news:title>Lilly Says Compounded Tirzepatide With Added Vitamin B12 Contains Impurities. Is It Safe? - Everyday Health</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-14-eli-lilly-finds-impurity-in-compounded-tirzepatide-pharmaceu/</loc><lastmod>2026-03-14T07:58:54+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-14-eli-lilly-finds-impurity-in-compounded-tirzepatide-pharmaceu/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-14-eli-lilly-finds-impurity-in-compounded-tirzepatide-pharmaceu/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-14T07:58:54+01:00</news:publication_date><news:title>Eli Lilly finds impurity in compounded tirzepatide - Pharmaceutical Technology</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-14-in-latest-compounding-clash-lilly-flags-high-levels-of-impur/</loc><lastmod>2026-03-14T07:58:46+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-14-in-latest-compounding-clash-lilly-flags-high-levels-of-impur/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-14-in-latest-compounding-clash-lilly-flags-high-levels-of-impur/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-14T07:58:46+01:00</news:publication_date><news:title>In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12 - Fierce Pharma</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-13-lilly-warns-of-impurity-in-compounded-versions-of-tirzepatid/</loc><lastmod>2026-03-13T09:05:39+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-13-lilly-warns-of-impurity-in-compounded-versions-of-tirzepatid/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-13-lilly-warns-of-impurity-in-compounded-versions-of-tirzepatid/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-13T09:05:39+01:00</news:publication_date><news:title>Lilly warns of impurity in compounded versions of tirzepatide - FirstWord Pharma</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-13-impurity-in-some-compounded-tirzepatide-potentially-dangerou/</loc><lastmod>2026-03-13T09:05:30+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-13-impurity-in-some-compounded-tirzepatide-potentially-dangerou/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-13-impurity-in-some-compounded-tirzepatide-potentially-dangerou/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-13T09:05:30+01:00</news:publication_date><news:title>Impurity in Some Compounded Tirzepatide 'Potentially Dangerous,' Eli Lilly Warns - MedPage Today</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-13-an-open-letter-from-eli-lilly-and-company-warning-of-potenti/</loc><lastmod>2026-03-13T09:05:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-13-an-open-letter-from-eli-lilly-and-company-warning-of-potenti/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-13-an-open-letter-from-eli-lilly-and-company-warning-of-potenti/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-13T09:05:23+01:00</news:publication_date><news:title>An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-12-ce-medicament-prescrit-contre-l-obesite-fait-perdre-jusqu-a-/</loc><lastmod>2026-03-12T09:11:46+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-12-ce-medicament-prescrit-contre-l-obesite-fait-perdre-jusqu-a-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-12-ce-medicament-prescrit-contre-l-obesite-fait-perdre-jusqu-a-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-12T09:11:46+01:00</news:publication_date><news:title>Ce médicament prescrit contre l’obésité fait perdre jusqu’à 20 % de son poids initial, mais son arrêt inquiète la médecine car il entraîne une reprise rapide des kilos et un impact immédiat sur la santé cardiovasculaire - Science et vie</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-12-mounjaro-wegovy-la-prescription-des-traitements-de-l-obesite/</loc><lastmod>2026-03-12T09:11:38+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-12-mounjaro-wegovy-la-prescription-des-traitements-de-l-obesite/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-12-mounjaro-wegovy-la-prescription-des-traitements-de-l-obesite/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-12T09:11:38+01:00</news:publication_date><news:title>Mounjaro, Wegovy - La prescription des traitements de l’obésité est étendue - Actualité - Que Choisir</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-12-lilly-finds-impurity-in-compounded-version-of-its-weight-los/</loc><lastmod>2026-03-12T09:11:25+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-12-lilly-finds-impurity-in-compounded-version-of-its-weight-los/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-12-lilly-finds-impurity-in-compounded-version-of-its-weight-los/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-12T09:11:25+01:00</news:publication_date><news:title>Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-11-which-glp-1-drug-has-the-highest-risk-of-sudden-sight-loss-a/</loc><lastmod>2026-03-11T08:06:24+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-11-which-glp-1-drug-has-the-highest-risk-of-sudden-sight-loss-a/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-11-which-glp-1-drug-has-the-highest-risk-of-sudden-sight-loss-a/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-11T08:06:24+01:00</news:publication_date><news:title>Which GLP-1 drug has the highest risk of sudden sight loss and ‘eye stroke’: study - New York Post</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-11-wegovy-users-have-five-times-greater-risk-of-sudden-sight-lo/</loc><lastmod>2026-03-11T08:06:16+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-11-wegovy-users-have-five-times-greater-risk-of-sudden-sight-lo/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-11-wegovy-users-have-five-times-greater-risk-of-sudden-sight-lo/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-11T08:06:16+01:00</news:publication_date><news:title>Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds - The Guardian</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-10-medicaments-anti-obesite-la-prescription-elargie-a-tous-les-/</loc><lastmod>2026-03-10T08:05:56+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-10-medicaments-anti-obesite-la-prescription-elargie-a-tous-les-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-10-medicaments-anti-obesite-la-prescription-elargie-a-tous-les-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-10T08:05:56+01:00</news:publication_date><news:title>Médicaments anti-obésité : la prescription élargie à tous les médecins en France</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-10-mounjaro-cleared-for-type-2-diabetes-in-eu-children/</loc><lastmod>2026-03-10T08:05:48+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-10-mounjaro-cleared-for-type-2-diabetes-in-eu-children/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-10-mounjaro-cleared-for-type-2-diabetes-in-eu-children/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-10T08:05:48+01:00</news:publication_date><news:title>Mounjaro Cleared for Type 2 Diabetes in EU Children</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-10-lilly-rewards-ceo-david-ricks-with-36-7m-pay-package-for-202/</loc><lastmod>2026-03-10T08:05:40+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-10-lilly-rewards-ceo-david-ricks-with-36-7m-pay-package-for-202/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-10-lilly-rewards-ceo-david-ricks-with-36-7m-pay-package-for-202/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-10T08:05:40+01:00</news:publication_date><news:title>Lilly rewards CEO David Ricks with $36.7M pay package for 2025, fueled by GLP-1 success - Fierce Pharma</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-09-two-deaths-reported-to-drug-watchdog-over-potential-link-to-/</loc><lastmod>2026-03-09T09:11:00+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-09-two-deaths-reported-to-drug-watchdog-over-potential-link-to-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-09-two-deaths-reported-to-drug-watchdog-over-potential-link-to-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-09T09:11:00+01:00</news:publication_date><news:title>Two deaths reported to drug watchdog over potential link to weight-loss jabs</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-09-eli-lilly-employer-connect-launch-puts-obesity-drug-push-and/</loc><lastmod>2026-03-09T05:18:21+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-09-eli-lilly-employer-connect-launch-puts-obesity-drug-push-and/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-09-eli-lilly-employer-connect-launch-puts-obesity-drug-push-and/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-09T05:18:21+01:00</news:publication_date><news:title>Eli Lilly Employer Connect Launch Puts Obesity Drug Push And Rich Valuation Under The Microscope</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-09-glp-1-drugs-like-ozempic-can-raise-bone-and-tendon-injury-ri/</loc><lastmod>2026-03-09T05:18:14+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-09-glp-1-drugs-like-ozempic-can-raise-bone-and-tendon-injury-ri/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-09-glp-1-drugs-like-ozempic-can-raise-bone-and-tendon-injury-ri/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-09T05:18:14+01:00</news:publication_date><news:title>GLP-1 drugs like Ozempic can raise bone and tendon injury risk, study suggests - The Detroit News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-08-la-nouvelle-generation-des-medicaments-contre-l-obesite-qub-/</loc><lastmod>2026-03-08T07:52:56+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-08-la-nouvelle-generation-des-medicaments-contre-l-obesite-qub-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-08-la-nouvelle-generation-des-medicaments-contre-l-obesite-qub-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-08T07:52:56+01:00</news:publication_date><news:title>La nouvelle génération des médicaments contre l'obésité - QUB radio</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-08-wegovy-saxenda-mounjaro-prescription-elargie-a-tout-medecin-/</loc><lastmod>2026-03-08T07:52:49+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-08-wegovy-saxenda-mounjaro-prescription-elargie-a-tout-medecin-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-08-wegovy-saxenda-mounjaro-prescription-elargie-a-tout-medecin-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-08T07:52:49+01:00</news:publication_date><news:title>WEGOVY, SAXENDA, MOUNJARO : prescription élargie à tout médecin, y compris en initiation de traitement</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-08-what-are-glp-1s-uses-for-weight-loss-diabetes-and-more/</loc><lastmod>2026-03-08T07:52:41+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-08-what-are-glp-1s-uses-for-weight-loss-diabetes-and-more/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-08-what-are-glp-1s-uses-for-weight-loss-diabetes-and-more/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-08T07:52:41+01:00</news:publication_date><news:title>What Are GLP-1s? Uses for Weight Loss, Diabetes, and More</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-07-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/</loc><lastmod>2026-03-07T07:51:37+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-07-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-07-eli-lilly-continue-a-prendre-de-l-embonpoint-sur-un-marche-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-07T07:51:37+01:00</news:publication_date><news:title>Eli Lilly continue à prendre de l'embonpoint, sur un marché de plus en plus concurrentiel - Les Echos</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-07-ozempic-wegovy-similar-drugs-what-the-lawsuits-are-about-the/</loc><lastmod>2026-03-07T07:51:28+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-07-ozempic-wegovy-similar-drugs-what-the-lawsuits-are-about-the/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-07-ozempic-wegovy-similar-drugs-what-the-lawsuits-are-about-the/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-07T07:51:28+01:00</news:publication_date><news:title>Ozempic, Wegovy &amp; Similar Drugs: What the Lawsuits Are About - The National Law Review</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-06-augmentation-des-ventes-de-medicaments-contre-l-obesite-au-p/</loc><lastmod>2026-03-06T08:02:24+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-06-augmentation-des-ventes-de-medicaments-contre-l-obesite-au-p/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-06-augmentation-des-ventes-de-medicaments-contre-l-obesite-au-p/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-06T08:02:24+01:00</news:publication_date><news:title>Augmentation des ventes de médicaments contre l'obésité au Portugal - The Portugal News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-06-quitting-mounjaro-and-wegovy-jabs-might-actually-leave-you-w/</loc><lastmod>2026-03-06T08:02:15+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-06-quitting-mounjaro-and-wegovy-jabs-might-actually-leave-you-w/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-06-quitting-mounjaro-and-wegovy-jabs-might-actually-leave-you-w/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-06T08:02:15+01:00</news:publication_date><news:title>Quitting Mounjaro and Wegovy jabs might actually leave you worse off than before</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-06-new-analysis-of-glp-1-drugs-suggests-people-who-stopped-usin/</loc><lastmod>2026-03-06T08:02:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-06-new-analysis-of-glp-1-drugs-suggests-people-who-stopped-usin/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-06-new-analysis-of-glp-1-drugs-suggests-people-who-stopped-usin/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-06T08:02:06+01:00</news:publication_date><news:title>New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost - ABC News</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-05-what-will-change-in-canada-when-generic-ozempic-hits-the-mar/</loc><lastmod>2026-03-05T08:05:31+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-05-what-will-change-in-canada-when-generic-ozempic-hits-the-mar/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-05-what-will-change-in-canada-when-generic-ozempic-hits-the-mar/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-05T08:05:31+01:00</news:publication_date><news:title>What will change in Canada when generic Ozempic hits the market, according to our reporters - The Globe and Mail</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-05-drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-afr/</loc><lastmod>2026-03-05T08:05:24+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-05-drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-afr/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-05-drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-afr/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-05T08:05:24+01:00</news:publication_date><news:title>Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-05-ozempic-like-weight-loss-drugs-may-help-the-heart-recover-af/</loc><lastmod>2026-03-05T08:05:16+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-05-ozempic-like-weight-loss-drugs-may-help-the-heart-recover-af/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-05-ozempic-like-weight-loss-drugs-may-help-the-heart-recover-af/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-05T08:05:16+01:00</news:publication_date><news:title>Ozempic-like weight loss drugs may help the heart recover after a heart attack</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-04-la-fda-americaine-met-en-garde-30-societes-de-telesante-cont/</loc><lastmod>2026-03-04T08:03:11+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-04-la-fda-americaine-met-en-garde-30-societes-de-telesante-cont/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-04-la-fda-americaine-met-en-garde-30-societes-de-telesante-cont/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-04T08:03:11+01:00</news:publication_date><news:title>La FDA américaine met en garde 30 sociétés de télésanté contre des publicités trompeuses pour des médicaments</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-04-clean-eatz-kitchen-launches-subscription-free-glp-1-meal-pla/</loc><lastmod>2026-03-04T08:03:03+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-04-clean-eatz-kitchen-launches-subscription-free-glp-1-meal-pla/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-04-clean-eatz-kitchen-launches-subscription-free-glp-1-meal-pla/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-04T08:03:03+01:00</news:publication_date><news:title>Clean Eatz Kitchen Launches Subscription-Free GLP-1 Meal Plan for Ozempic®, Wegovy®, and Mounjaro® Users - PR Newswire</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-04-keytruda-hangs-on-to-best-seller-crown-as-glp-1s-gain-ground/</loc><lastmod>2026-03-04T08:02:55+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-04-keytruda-hangs-on-to-best-seller-crown-as-glp-1s-gain-ground/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-04-keytruda-hangs-on-to-best-seller-crown-as-glp-1s-gain-ground/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-04T08:02:55+01:00</news:publication_date><news:title>Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-03-mounjaro-health-benefits-found-to-reverse-one-year-after-sto/</loc><lastmod>2026-03-03T08:06:01+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-03-mounjaro-health-benefits-found-to-reverse-one-year-after-sto/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-03-mounjaro-health-benefits-found-to-reverse-one-year-after-sto/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-03T08:06:01+01:00</news:publication_date><news:title>Mounjaro health benefits found to reverse one year after stopping drug - The Pharmaceutical Journal</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-03-tirzepatide-as-compared-with-semaglutide-for-the-treatment-o/</loc><lastmod>2026-03-03T08:05:53+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-03-tirzepatide-as-compared-with-semaglutide-for-the-treatment-o/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-03-tirzepatide-as-compared-with-semaglutide-for-the-treatment-o/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-03T08:05:53+01:00</news:publication_date><news:title>Tirzepatide as Compared with Semaglutide for the Treatment of Obesity | New England Journal of Medicine - The New England Journal of Medicine</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-03-vital-signs-pharma-s-fastest-growing-drugs/</loc><lastmod>2026-03-03T08:05:46+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-03-vital-signs-pharma-s-fastest-growing-drugs/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-03-vital-signs-pharma-s-fastest-growing-drugs/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-03T08:05:46+01:00</news:publication_date><news:title>Vital Signs: Pharma's fastest growing drugs</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-02-allurion-announces-partnership-to-offer-combination-therapy-/</loc><lastmod>2026-03-02T09:34:40+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-02-allurion-announces-partnership-to-offer-combination-therapy-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-02-allurion-announces-partnership-to-offer-combination-therapy-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-02T09:34:40+01:00</news:publication_date><news:title>Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices - Yahoo Finance</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-02-weight-loss-drug-linked-to-lower-risk-of-eye-disease-in-pati/</loc><lastmod>2026-03-02T09:34:33+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-02-weight-loss-drug-linked-to-lower-risk-of-eye-disease-in-pati/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-02-weight-loss-drug-linked-to-lower-risk-of-eye-disease-in-pati/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-02T09:34:33+01:00</news:publication_date><news:title>Weight-Loss Drug Linked to Lower Risk of Eye Disease in Patients with Diabetes - WCM Newsroom</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-02-eli-lilly-s-weight-loss-and-diabetes-drug-tops-keytruda-as-w/</loc><lastmod>2026-03-02T09:34:24+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-02-eli-lilly-s-weight-loss-and-diabetes-drug-tops-keytruda-as-w/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-02-eli-lilly-s-weight-loss-and-diabetes-drug-tops-keytruda-as-w/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-02T09:34:24+01:00</news:publication_date><news:title>Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/</loc><lastmod>2026-03-01T18:18:06+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T18:18:06+01:00</news:publication_date><news:title>Interview exclusive — Dr Myriam Rosilio (Lilly France) : « Tirzépatide, des résultats inédits sur le cœur »</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/</loc><lastmod>2026-03-01T18:17:59+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-nouveau-medicament-injectable-indique-dans-le-trait/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T18:17:59+01:00</news:publication_date><news:title>MOUNJARO : nouveau médicament injectable indiqué dans le traitement du diabète de type 2 et de l'obésité</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/</loc><lastmod>2026-03-01T17:56:41+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-obesite-remboursement-de-mounjaro/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:41+01:00</news:publication_date><news:title>Obésité : remboursement de Mounjaro</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/</loc><lastmod>2026-03-01T17:56:32+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-why-medical-experts-say-kenyans-should-be-cautious-/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:32+01:00</news:publication_date><news:title>Mounjaro: Why medical experts say Kenyans should be cautious - Daily Nation</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/</loc><lastmod>2026-03-01T17:56:23+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-wegovy-vs-mounjaro-8-important-differences/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T17:56:23+01:00</news:publication_date><news:title>Wegovy vs. Mounjaro: 8 Important Differences</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/</loc><lastmod>2026-03-01T07:54:10+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-note-d-allurion-technologies-relevee-suite-a-l-approbation-d/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:54:10+01:00</news:publication_date><news:title>Note d’Allurion Technologies relevée suite à l’approbation de la FDA - Investing.com France</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/</loc><lastmod>2026-03-01T07:54:02+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-que-se-passe-t-il-lorsqu-on-arrete-les-glp-1/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:54:02+01:00</news:publication_date><news:title>Que se passe-t-il lorsqu'on arrête les GLP-1 ?</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/</loc><lastmod>2026-03-01T07:53:54+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-eye-side-effects-lawsuit-2026-update/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T07:53:54+01:00</news:publication_date><news:title>Mounjaro Eye Side Effects Lawsuit [2026 Update]</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/</loc><lastmod>2026-03-01T00:18:42+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-mounjaro-la-has-revise-a-la-hausse-l-amelioration-du-service/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:42+01:00</news:publication_date><news:title>Mounjaro : la HAS révise à la hausse l’amélioration du service médical rendu dans l’obésité</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/</loc><lastmod>2026-03-01T00:18:34+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-c-est-dramatique-ce-medicament-pris-par-des-millions-de-pers/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:34+01:00</news:publication_date><news:title>"C'est dramatique" : ce médicament pris par des millions de personnes fait grossir dès qu'on l'arrête - Journal des Femmes Santé</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/</loc><lastmod>2026-03-01T00:18:26+01:00</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/posts/2026-03-01-medicament-anti-obesite-la-haute-autorite-de-sante-donne-son/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-03-01T00:18:26+01:00</news:publication_date><news:title>Médicament anti-obésité : la Haute autorité de santé donne son feu vert au remboursement de Mounjaro - Le Figaro Santé</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1, news.google.com</news:keywords></news:news></url><url><loc>https://mounjaronews.info/mentions-legales/</loc><lastmod>2026-01-01T00:00:00Z</lastmod><changefreq>weekly</changefreq><priority>0.8</priority><xhtml:link rel="alternate" hreflang="fr" href="https://mounjaronews.info/mentions-legales/"/><xhtml:link rel="alternate" hreflang="en" href="https://mounjaronews.info/mentions-legales/"/><news:news><news:publication><news:name>Mounjaro News</news:name><news:language>fr</news:language></news:publication><news:publication_date>2026-01-01T00:00:00Z</news:publication_date><news:title>Mentions légales &amp; Politique de confidentialité</news:title><news:keywords>Mounjaro, tirzepatide, tirzépatide, GLP-1</news:keywords></news:news></url></urlset>